Developed in collaboration with

This whitepaper was funded by Bristol Myers Squibb (BMS) and guided by a multidisciplinary Expert Advisory Group (EAG). This EAG brought together patient advocates, caregiver representatives, health policy experts, academics, and clinicians, ensuring that the perspectives of those directly affected — and those shaping cancer care policy and practice — were embedded throughout.

Fill out the form on the right to download the whitepaper.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Sign me up to receive regular insights from Lumanity
By selecting this box, I consent to receive Lumanity marketing communications by email.